Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002)
Clinical trial NCT01640873 · COMPLETED
Trial details
- NCT number
- NCT01640873
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-19
- Primary completion
- 2012-12-20
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.